What Do We Know So Far about Ofatumumab for Relapsing Multiple Sclerosis? A Meta-Analytical Study

  • Hafiza Munazza Taj
  • , Maryam Talib
  • , Sania Siddiqa
  • , Azza Sarfraz
  • , Zouina Sarfraz
  • , Karla Robles-Velasco
  • , Ivan Cherrez-Ojeda

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'What Do We Know So Far about Ofatumumab for Relapsing Multiple Sclerosis? A Meta-Analytical Study'. Together they form a unique fingerprint.

Neuroscience

Immunology and Microbiology